Optical Biosensors for the Detection of Biomarkers
A special issue of Sensors (ISSN 1424-8220). This special issue belongs to the section "Biosensors".
Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 762
Special Issue Editors
Interests: nanomedicine and biophotonics techniques for monitoring the rehabilitative treatment efficacy; exosomes for regenerative medicine application and biomarkers discovery
Interests: biophotonics; biosensors; biomedical applications; clinical diagnostics; point-of-care; surface plasmon resonance; raman spectroscopy; nanomedicine; extracellular vesicles
Special Issue Information
Dear Colleagues,
The development of rapid, sensitive and easily applicable platforms for the specific detection of biomolecules represents a relevant clinical requirement for the management of several diseases. Indeed, the objective evaluation of the presence and concentration of molecules potentially involved in the pathogenesis of a specific disease can enable the early diagnosis and/or monitoring of pathological progression, assessing the efficacy of pharmacological or rehabilitative treatments for personalized medicine. Optical biosensors offer great advantages, representing the most common type of biosensors due to their demonstrated capabilities of high specificity, sensitivity, high speed and cost-effectiveness once implemented.
The aim of this Special Issue is to present the current evolution of optical biosensors for the sensitive and specific detection of new, or already discovered, disease-related biomarkers, responding to urgent unmet clinical needs concerning specific disease management. We invite authors to submit examples of optical biosensors—both label-free and label-based—for healthcare, enabling the detection of protein-, enzyme-, antibody-, cell- or nucleic acid-based biomarkers as single molecules or complex mixtures present in biological fluids. Discussions or demonstrations with regard to the potentiality and feasibility of the presented biosensors to be translated to clinical practice in the next future are encouraged, for example, point-of-care systems or home-testing, as high-throughput sensitive screening or diagnostic and monitoring tests.
Dr. Marzia Bedoni
Dr. Silvia Picciolini
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Sensors is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- optical biosensors
- analytical device design
- biomarkers
- liquid biopsy
- healthcare
- point-of-care devices
- disease diagnostics
- disease monitoring
